과학
기타
Povorcitinib beneficial for moderate-to-severe hidradenitis suppurativa
Medical Xpress
For patients with moderate-to-severe hidradenitis suppurativa (HS), povorcitinib (an oral Janus kinase 1 inhibitor) is beneficial, according to a study published online July 23 in Nature Medicine. ...
이 뉴스, 어떠셨어요?
탭 한 번으로 반응 · 로그인 불필요
관련 뉴스
관련 뉴스 제보는 로그인 후 가능합니다.
'science' 카테고리 뉴스
Medical Xpress의 다른 기사
Indigenous Australians want to use cultural medicines more often, but access remains difficult
Medical Xpress
Despite progress towards eliminating hepatitis in Europe, gaps in prevention measures keep 2030 targets out of reach
Medical Xpress
Few young adults receive palliative care as part of advanced cancer treatment
Medical Xpress